Mirion to Present at the 46th Annual Raymond James Institutional Investor Conference
Mirion Technologies (NYSE: MIR) has announced its participation in the 46th Annual Raymond James Institutional Investor Conference. The company's leadership team, including CEO Thomas Logan and CFO Brian Schopfer, will deliver a presentation scheduled for Wednesday, March 5, 2025, at 9:15 a.m. ET.
The presentation will be accessible through a live webcast on Mirion's Investor Relations Page under the 'Events and Presentations' section. An archived version of the webcast will also be made available at the same location for those unable to attend the live session.
Mirion Technologies (NYSE: MIR) ha annunciato la sua partecipazione alla 46ª Conferenza Annuale degli Investitori Istituzionali di Raymond James. Il team di leadership dell'azienda, compresi il CEO Thomas Logan e il CFO Brian Schopfer, presenterà una relazione programmata per mercoledì 5 marzo 2025, alle 9:15 a.m. ET.
La presentazione sarà accessibile tramite un webcast in diretta sulla pagina delle Relazioni con gli Investitori di Mirion, nella sezione 'Eventi e Presentazioni'. Una versione archiviata del webcast sarà anche disponibile nello stesso luogo per coloro che non possono partecipare alla sessione dal vivo.
Mirion Technologies (NYSE: MIR) ha anunciado su participación en la 46ª Conferencia Anual de Inversores Institucionales de Raymond James. El equipo de liderazgo de la empresa, que incluye al CEO Thomas Logan y al CFO Brian Schopfer, realizará una presentación programada para miércoles 5 de marzo de 2025, a las 9:15 a.m. ET.
La presentación será accesible a través de una transmisión en vivo en la página de Relaciones con Inversores de Mirion, en la sección 'Eventos y Presentaciones'. También se pondrá a disposición una versión archivada de la transmisión en el mismo lugar para aquellos que no puedan asistir a la sesión en vivo.
Mirion Technologies (NYSE: MIR)는 제46회 레이몬드 제임스 기관 투자자 회의에 참여한다고 발표했습니다. CEO 토마스 로건과 CFO 브라이언 쇼퍼를 포함한 회사의 리더십 팀이 2025년 3월 5일 수요일 오전 9시 15분 ET에 예정된 발표를 진행할 것입니다.
발표는 Mirion의 투자자 관계 페이지의 '이벤트 및 발표' 섹션에서 실시간 웹캐스트를 통해 접근할 수 있습니다. 라이브 세션에 참석할 수 없는 분들을 위해 같은 장소에 웹캐스트의 아카이브 버전도 제공될 예정입니다.
Mirion Technologies (NYSE: MIR) a annoncé sa participation à la 46e Conférence Annuelle des Investisseurs Institutionnels de Raymond James. L'équipe de direction de l'entreprise, y compris le PDG Thomas Logan et le CFO Brian Schopfer, présentera une intervention prévue pour mercredi 5 mars 2025, à 9h15 ET.
La présentation sera accessible via un webinaire en direct sur la page des Relations Investisseurs de Mirion, dans la section 'Événements et Présentations'. Une version archivée du webinaire sera également disponible au même endroit pour ceux qui ne peuvent pas assister à la session en direct.
Mirion Technologies (NYSE: MIR) hat seine Teilnahme an der 46. jährlichen Raymond James Institutional Investor Conference bekannt gegeben. Das Führungsteam des Unternehmens, einschließlich CEO Thomas Logan und CFO Brian Schopfer, wird eine Präsentation halten, die für Mittwoch, den 5. März 2025, um 9:15 Uhr ET angesetzt ist.
Die Präsentation wird über einen Live-Webcast auf der Investor-Relations-Seite von Mirion im Abschnitt 'Veranstaltungen und Präsentationen' zugänglich sein. Eine archivierte Version des Webcasts wird ebenfalls an derselben Stelle zur Verfügung gestellt, für diejenigen, die nicht an der Live-Sitzung teilnehmen können.
- None.
- None.
The presentation will be webcast live at Mirion's Investor Relations Page. The link will be displayed under the “Events and Presentations” section. An archive of the webcast will be available as well at the same location.
About Mirion
Mirion (NYSE: MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. The Mirion Nuclear & Safety group provides proven radiation safety technologies that operate with precision – for essential work within R&D labs, critical nuclear facilities, and on the front lines. The Mirion Medical group solutions help enhance the delivery and ensure safety in healthcare, powering the fields of Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry, and Diagnostic Imaging. Headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20250225952691/en/
For investor inquiries:
Eric Linn
ir@mirion.com
For media inquiries:
Erin Schesny
media@mirion.com
Source: Mirion
FAQ
When is Mirion (MIR) presenting at the Raymond James Conference 2025?
How can investors watch Mirion's (MIR) Raymond James Conference presentation?
Will Mirion's (MIR) Raymond James Conference presentation be available after the event?
Which Mirion (MIR) executives are presenting at the Raymond James Conference 2025?
